Harry Schwartz

604 total citations
17 papers, 443 citations indexed

About

Harry Schwartz is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Harry Schwartz has authored 17 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Harry Schwartz's work include Enzyme Catalysis and Immobilization (4 papers), Cardiac Imaging and Diagnostics (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Harry Schwartz is often cited by papers focused on Enzyme Catalysis and Immobilization (4 papers), Cardiac Imaging and Diagnostics (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Harry Schwartz collaborates with scholars based in Germany, United States and Italy. Harry Schwartz's co-authors include Alan G. Wasserman, Allan M. Ross, P.Jacob Varghese, George B. Bren, Richard J. Katz, Roy H. Leiboff, Wei Zou, Stefan Endres, Zvi Bar‐Shavit and Gunther Hartmann and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Harry Schwartz

17 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Schwartz Germany 10 231 169 151 100 37 17 443
Hiromichi Nakajima Japan 14 177 0.8× 34 0.2× 104 0.7× 141 1.4× 24 0.6× 52 561
Kazushi Yukiiri Japan 13 286 1.2× 77 0.5× 100 0.7× 100 1.0× 13 0.4× 40 706
Maria Mitry United States 6 204 0.9× 46 0.3× 49 0.3× 99 1.0× 14 0.4× 6 392
Felix Schiele Germany 9 389 1.7× 38 0.2× 71 0.5× 169 1.7× 45 1.2× 13 682
W J van der Vijgh Netherlands 11 122 0.5× 37 0.2× 29 0.2× 141 1.4× 9 0.2× 11 439
Yukiyo Ogata Japan 9 94 0.4× 34 0.2× 94 0.6× 140 1.4× 55 1.5× 17 345
Takashi Ohtani Japan 13 132 0.6× 66 0.4× 61 0.4× 55 0.6× 10 0.3× 40 433
Loretta Fala United States 14 58 0.3× 21 0.1× 77 0.5× 117 1.2× 56 1.5× 24 392
David G. Jones United Kingdom 19 906 3.9× 178 1.1× 83 0.5× 330 3.3× 9 0.2× 49 1.4k
Douglas P. Chadwick United States 7 357 1.5× 62 0.4× 13 0.1× 88 0.9× 23 0.6× 8 478

Countries citing papers authored by Harry Schwartz

Since Specialization
Citations

This map shows the geographic impact of Harry Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Schwartz more than expected).

Fields of papers citing papers by Harry Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Schwartz. The network helps show where Harry Schwartz may publish in the future.

Co-authorship network of co-authors of Harry Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Schwartz. A scholar is included among the top collaborators of Harry Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Schwartz. Harry Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hoppe, Edmund, Nicola J. Hewitt, Hans‐Peter Buchstaller, et al.. (2014). A Novel Strategy for ADME Screening of Prodrugs: Combined Use of Serum and Hepatocytes to Integrate Bioactivation and Clearance, and Predict Exposure to Both Active and Prodrug to the Systemic Circulation. Journal of Pharmaceutical Sciences. 103(5). 1504–1514. 8 indexed citations
2.
Buchstaller, Hans‐Peter, Hans‐Michael Eggenweiler, Christian Sirrenberg, et al.. (2012). Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90. Bioorganic & Medicinal Chemistry Letters. 22(13). 4396–4403. 14 indexed citations
3.
Sirrenberg, Christian, Hans‐Michael Eggenweiler, Hans‐Peter Buchstaller, et al.. (2010). Abstract 2639: Discovery of novel small molecule inhibitors of Hsp90 for oral treatment. Cancer Research. 70(8_Supplement). 2639–2639. 1 indexed citations
4.
Heinrich, Timo, Henning Böttcher, Gerd D. Bartoszyk, et al.. (2004). Bioisosterism of Fluorine and Cyano as Indole Substituents. Theoretical, in vitro and in vivo Examination. CHIMIA International Journal for Chemistry. 58(3). 143–143. 4 indexed citations
5.
Zou, Wei, Harry Schwartz, Stefan Endres, Gunther Hartmann, & Zvi Bar‐Shavit. (2002). CpG oligonucleotides: novel regulators of osteoclast differentiation. The FASEB Journal. 16(3). 274–282. 50 indexed citations
6.
Mederski, Werner W. K. R., Dieter Dorsch, Harry Schwartz, et al.. (1997). Novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridines. Potent angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes. European Journal of Medicinal Chemistry. 32(6). 479–491. 7 indexed citations
7.
Schwartz, Harry, et al.. (1996). Microbial oxidation of ebastine. Applied Microbiology and Biotechnology. 44(6). 731–735. 16 indexed citations
8.
Schwartz, Harry, et al.. (1993). Microbial metabolism of the \-adrenoreceptor antagonist bisoprolol. Applied Microbiology and Biotechnology. 40(2-3). 382–5. 10 indexed citations
9.
Hemberger, Jürgen, et al.. (1992). Studies on the enzymatic reduction of N-Boc-4S-amino-3-oxo-5-phenylpentanoic acid methylester. Journal of Biotechnology. 26(2-3). 183–201. 10 indexed citations
10.
Schwartz, Harry, et al.. (1991). Nitrate reductase from yeast: cultivation, partial purification and characterization. Applied Microbiology and Biotechnology. 35(4). 4 indexed citations
11.
Raddatz, Peter, et al.. (1988). Reduktion mit Hefezellen, der Schlüsselschritt einer effizienten Synthese von (3S,4S)‐4‐Amino‐3‐hydroxypentansäuren. Angewandte Chemie. 100(3). 414–415. 4 indexed citations
12.
Raddatz, Peter, et al.. (1988). Reduction with Yeast Cells, the Key Step of an Efficient Synthesis of (3S, 4S)‐4‐Amino‐3‐hydroxypentanoic Acids. Angewandte Chemie International Edition in English. 27(3). 426–427. 14 indexed citations
13.
Hsu, Irene, et al.. (1986). Congenital Aneurysm of the Left Sinus of Valsalva. CHEST Journal. 90(1). 143–145. 15 indexed citations
14.
Schwartz, Harry, Richard J. Katz, Alan G. Wasserman, et al.. (1985). Arteriographic predictors of spontaneous improvement in left ventricular function after myocardial infarction.. Circulation. 71(3). 466–472. 41 indexed citations
15.
Schwartz, Harry, Roy H. Leiboff, George B. Bren, et al.. (1984). Temporal evolution of the human coronary collateral circulation after myocardial infarction. Journal of the American College of Cardiology. 4(6). 1088–1093. 95 indexed citations
16.
Leiboff, Roy H., Richard J. Katz, Alan G. Wasserman, et al.. (1984). A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. The American Journal of Cardiology. 53(4). 404–407. 145 indexed citations
17.
Heilbrun, Alfred B. & Harry Schwartz. (1980). Self-esteem and self-reinforcement in men alcoholics.. Journal of Studies on Alcohol. 41(11). 1134–1142. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromichi Nakajima Breakdown of academic impact, for papers by Kazushi Yukiiri Breakdown of academic impact, for papers by Maria Mitry Breakdown of academic impact, for papers by Felix Schiele Breakdown of academic impact, for papers by W J van der Vijgh Breakdown of academic impact, for papers by Yukiyo Ogata Breakdown of academic impact, for papers by Takashi Ohtani Breakdown of academic impact, for papers by Loretta Fala Breakdown of academic impact, for papers by David G. Jones Breakdown of academic impact, for papers by Douglas P. Chadwick
Rankless by CCL
2026